GB201721259D0 - Bicyclic peptide ligands specific for EphA2 - Google Patents

Bicyclic peptide ligands specific for EphA2

Info

Publication number
GB201721259D0
GB201721259D0 GBGB1721259.8A GB201721259A GB201721259D0 GB 201721259 D0 GB201721259 D0 GB 201721259D0 GB 201721259 A GB201721259 A GB 201721259A GB 201721259 D0 GB201721259 D0 GB 201721259D0
Authority
GB
United Kingdom
Prior art keywords
epha2
peptide ligands
ligands specific
bicyclic peptide
bicyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1721259.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BicycleTx Ltd
Original Assignee
Bicycle Therapeutics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bicycle Therapeutics PLC filed Critical Bicycle Therapeutics PLC
Priority to GBGB1721259.8A priority Critical patent/GB201721259D0/en
Publication of GB201721259D0 publication Critical patent/GB201721259D0/en
Priority to TW107144453A priority patent/TWI825046B/en
Priority to US16/220,685 priority patent/US11484602B2/en
Priority to ARP180103703A priority patent/AR113966A1/en
Priority to AU2018387418A priority patent/AU2018387418B2/en
Priority to IL275440A priority patent/IL275440B2/en
Priority to DK18829437.5T priority patent/DK3727460T3/en
Priority to LTEPPCT/GB2018/053675T priority patent/LT3727460T/en
Priority to PL18829437.5T priority patent/PL3727460T3/en
Priority to MX2020006482A priority patent/MX2020006482A/en
Priority to AU2018387417A priority patent/AU2018387417B2/en
Priority to ES18829437T priority patent/ES2922632T3/en
Priority to SG11202005494QA priority patent/SG11202005494QA/en
Priority to KR1020207019675A priority patent/KR20200105839A/en
Priority to EP18829437.5A priority patent/EP3727460B1/en
Priority to EP22161978.6A priority patent/EP4053145A1/en
Priority to MX2020006474A priority patent/MX2020006474A/en
Priority to BR112020012246-7A priority patent/BR112020012246A2/en
Priority to BR112020012349-8A priority patent/BR112020012349A2/en
Priority to PCT/GB2018/053678 priority patent/WO2019122863A1/en
Priority to SG11202005495UA priority patent/SG11202005495UA/en
Priority to PCT/GB2018/053675 priority patent/WO2019122860A1/en
Priority to JP2020534623A priority patent/JP7293231B2/en
Priority to EP18829926.7A priority patent/EP3727461A1/en
Priority to CN201880089662.7A priority patent/CN111787955A/en
Priority to US16/771,186 priority patent/US11696956B2/en
Priority to SI201830718T priority patent/SI3727460T1/en
Priority to CN201880089757.9A priority patent/CN111741771A/en
Priority to PT188294375T priority patent/PT3727460T/en
Priority to KR1020207019676A priority patent/KR20200105840A/en
Priority to HUE18829437A priority patent/HUE059126T2/en
Priority to HRP20220871TT priority patent/HRP20220871T1/en
Priority to CA3085253A priority patent/CA3085253A1/en
Priority to JP2020534361A priority patent/JP7404241B2/en
Priority to CA3086257A priority patent/CA3086257A1/en
Priority to IL275437A priority patent/IL275437A/en
Priority to PH12020550929A priority patent/PH12020550929A1/en
Priority to US17/934,896 priority patent/US11833211B2/en
Priority to US18/313,983 priority patent/US20240000957A1/en
Priority to JP2023093890A priority patent/JP2023130345A/en
Ceased legal-status Critical Current

Links

GBGB1721259.8A 2017-12-19 2017-12-19 Bicyclic peptide ligands specific for EphA2 Ceased GB201721259D0 (en)

Priority Applications (40)

Application Number Priority Date Filing Date Title
GBGB1721259.8A GB201721259D0 (en) 2017-12-19 2017-12-19 Bicyclic peptide ligands specific for EphA2
TW107144453A TWI825046B (en) 2017-12-19 2018-12-11 Bicyclic peptide ligands specific for epha2
US16/220,685 US11484602B2 (en) 2017-12-19 2018-12-14 Bicyclic peptide ligands specific for EphA2
ARP180103703A AR113966A1 (en) 2017-12-19 2018-12-18 EphA2 SPECIFIC BICYCLIC PEPTIDES LIGANDS
CA3086257A CA3086257A1 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2
BR112020012349-8A BR112020012349A2 (en) 2017-12-19 2018-12-19 epha2-specific bicyclic peptide ligands
EP18829926.7A EP3727461A1 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2
DK18829437.5T DK3727460T3 (en) 2017-12-19 2018-12-19 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2
LTEPPCT/GB2018/053675T LT3727460T (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2
PL18829437.5T PL3727460T3 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2
MX2020006482A MX2020006482A (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2.
AU2018387417A AU2018387417B2 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for EphA2
ES18829437T ES2922632T3 (en) 2017-12-19 2018-12-19 EphA2-specific bicyclic peptide ligands
SG11202005494QA SG11202005494QA (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2
KR1020207019675A KR20200105839A (en) 2017-12-19 2018-12-19 Bicyclic peptide ligand specific for EphA2
EP18829437.5A EP3727460B1 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2
EP22161978.6A EP4053145A1 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2
MX2020006474A MX2020006474A (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2.
BR112020012246-7A BR112020012246A2 (en) 2017-12-19 2018-12-19 epha2-specific bicyclic peptide ligands
AU2018387418A AU2018387418B2 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for EphA2
PCT/GB2018/053678 WO2019122863A1 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2
SG11202005495UA SG11202005495UA (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2
PCT/GB2018/053675 WO2019122860A1 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2
JP2020534623A JP7293231B2 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for EphA2
IL275440A IL275440B2 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2
CN201880089662.7A CN111787955A (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for EphA2
US16/771,186 US11696956B2 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for EphA2
SI201830718T SI3727460T1 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2
CN201880089757.9A CN111741771A (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for EPHA2
PT188294375T PT3727460T (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2
KR1020207019676A KR20200105840A (en) 2017-12-19 2018-12-19 Bicyclic peptide ligand specific for EphA2
HUE18829437A HUE059126T2 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2
HRP20220871TT HRP20220871T1 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2
CA3085253A CA3085253A1 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligands specific for epha2
JP2020534361A JP7404241B2 (en) 2017-12-19 2018-12-19 Bicyclic peptide ligand specific for EphA2
PH12020550929A PH12020550929A1 (en) 2017-12-19 2020-06-17 Bicyclic peptide ligands specific for epha2
IL275437A IL275437A (en) 2017-12-19 2020-06-17 Bicyclic peptide ligands specific for epha2
US17/934,896 US11833211B2 (en) 2017-12-19 2022-09-23 Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2
US18/313,983 US20240000957A1 (en) 2017-12-19 2023-05-08 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2
JP2023093890A JP2023130345A (en) 2017-12-19 2023-06-07 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1721259.8A GB201721259D0 (en) 2017-12-19 2017-12-19 Bicyclic peptide ligands specific for EphA2

Publications (1)

Publication Number Publication Date
GB201721259D0 true GB201721259D0 (en) 2018-01-31

Family

ID=61008664

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1721259.8A Ceased GB201721259D0 (en) 2017-12-19 2017-12-19 Bicyclic peptide ligands specific for EphA2

Country Status (2)

Country Link
AR (1) AR113966A1 (en)
GB (1) GB201721259D0 (en)

Also Published As

Publication number Publication date
AR113966A1 (en) 2020-07-01

Similar Documents

Publication Publication Date Title
IL275437A (en) Bicyclic peptide ligands specific for epha2
ZA202100442B (en) Bicyclic peptide ligands specific for nectin-4
GB201721265D0 (en) Bicyclic peptide ligands specific for EphA2
GB201820316D0 (en) Bicyclic peptide ligands specific for IL-17
GB201820320D0 (en) Bicyclic peptide ligands specific for FAPalpha
GB201721259D0 (en) Bicyclic peptide ligands specific for EphA2
GB201707734D0 (en) Bicyclic peptide ligands specific for EphA2
GB201818603D0 (en) Bicyclic peptide ligands specific for epha2
GB201720934D0 (en) Bicyclic peptide ligands specific for FAPalpha
GB201712693D0 (en) Bicyclic peptide ligands specific for nectin-4
GB201818499D0 (en) Bicyclic peptide ligands specific for nectin-4
GB201815684D0 (en) Bicyclic peptide ligands specific for nectin-4
GB201720941D0 (en) Bicyclic peptide ligands specific for EPHA3
GB201720932D0 (en) Bicyclic peptide ligands specific for IL-17
GB201810321D0 (en) Peptide ligands for bindingto EphA2
GB201720928D0 (en) Bicyclic peptide ligands specific for IL-6
GB201621574D0 (en) Bicyclic peptide ligands specific for fapalpha
GB201720933D0 (en) Bicyclic peptide ligands specific for cathepsin G
GB201720940D0 (en) Bicyclic peptide ligands specific for PSMA
GB201701834D0 (en) Bicyclic peptide ligands specific for CD38
GB201715621D0 (en) Bicycle peptide ligands specific for EphA2
GB201720926D0 (en) Bicyclic peptide ligands specific for chymase
GB201720939D0 (en) Bicyclic peptide ligands specific for VEGF
GB201720936D0 (en) Bicyclic peptide ligands specific for TGFbeta
GB201712589D0 (en) Bicyclic peptide ligands specific for CD137

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: BICYCLETX LIMITED

Free format text: FORMER OWNER: BICYCLERD LIMITED

AT Applications terminated before publication under section 16(1)